NDC 46708-064

Rivastigmine Tartrate

Rivastigmine Tartrate

Rivastigmine Tartrate is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Alembic Pharmaceuticals Limited. The primary component is Rivastigmine Tartrate.

Product ID46708-064_33e6a772-382d-45f5-9d45-966c07759367
NDC46708-064
Product TypeHuman Prescription Drug
Proprietary NameRivastigmine Tartrate
Generic NameRivastigmine Tartrate
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2012-06-13
Marketing CategoryANDA / ANDA
Application NumberANDA091689
Labeler NameAlembic Pharmaceuticals Limited
Substance NameRIVASTIGMINE TARTRATE
Active Ingredient Strength3 mg/1
Pharm ClassesCholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 46708-064-10

100 BLISTER PACK in 1 BOX, UNIT-DOSE (46708-064-10) > 10 CAPSULE in 1 BLISTER PACK (46708-064-11)
Marketing Start Date2012-06-13
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 46708-064-91 [46708006491]

Rivastigmine Tartrate CAPSULE
Marketing CategoryANDA
Application NumberANDA091689
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-06-13

NDC 46708-064-30 [46708006430]

Rivastigmine Tartrate CAPSULE
Marketing CategoryANDA
Application NumberANDA091689
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-06-13

NDC 46708-064-71 [46708006471]

Rivastigmine Tartrate CAPSULE
Marketing CategoryANDA
Application NumberANDA091689
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-06-13

NDC 46708-064-11 [46708006411]

Rivastigmine Tartrate CAPSULE
Marketing CategoryANDA
Application NumberANDA091689
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-06-13

NDC 46708-064-10 [46708006410]

Rivastigmine Tartrate CAPSULE
Marketing CategoryANDA
Application NumberANDA091689
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-06-13

NDC 46708-064-60 [46708006460]

Rivastigmine Tartrate CAPSULE
Marketing CategoryANDA
Application NumberANDA091689
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-06-13

Drug Details

Active Ingredients

IngredientStrength
RIVASTIGMINE TARTRATE3 mg/1

OpenFDA Data

SPL SET ID:33e6a772-382d-45f5-9d45-966c07759367
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 312835
  • 314214
  • 314215
  • 312836
    • UPC Code
  • 0346708066307
  • 0346708064303
  • 0346708065300
  • 0346708063306

    • Pharmacological Class

    • Cholinesterase Inhibitor [EPC]
    • Cholinesterase Inhibitors [MoA]

    NDC Crossover Matching brand name "Rivastigmine Tartrate" or generic name "Rivastigmine Tartrate"

    NDCBrand NameGeneric Name
    0591-3208Rivastigmine TartrateRivastigmine Tartrate
    0591-3209Rivastigmine TartrateRivastigmine Tartrate
    0591-3210Rivastigmine TartrateRivastigmine Tartrate
    0591-3211Rivastigmine TartrateRivastigmine Tartrate
    0781-2614Rivastigmine Tartraterivastigmine tartrate
    0781-2615Rivastigmine Tartraterivastigmine tartrate
    0781-2616Rivastigmine Tartraterivastigmine tartrate
    0781-2617Rivastigmine Tartraterivastigmine tartrate
    0904-6587Rivastigmine TartrateRivastigmine Tartrate
    0904-7107Rivastigmine TartrateRivastigmine Tartrate
    27241-090RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    27241-091RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    27241-092RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    27241-093RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    33342-089RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    33342-090RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    33342-091RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    33342-092RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    46708-063Rivastigmine TartrateRivastigmine Tartrate
    46708-064Rivastigmine TartrateRivastigmine Tartrate
    46708-065Rivastigmine TartrateRivastigmine Tartrate
    46708-066Rivastigmine TartrateRivastigmine Tartrate
    68084-550Rivastigmine TartrateRivastigmine Tartrate
    68151-4134Rivastigmine TartrateRivastigmine Tartrate
    71209-012Rivastigmine TartrateRivastigmine Tartrate
    71209-013Rivastigmine TartrateRivastigmine Tartrate
    71209-014Rivastigmine TartrateRivastigmine Tartrate
    71209-015Rivastigmine TartrateRivastigmine Tartrate
    75834-136RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    75834-133RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    75834-134RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    75834-135RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
    51991-793Rivastigmine TartrateRivastigmine Tartrate
    51991-794Rivastigmine TartrateRivastigmine Tartrate
    51991-796Rivastigmine TartrateRivastigmine Tartrate
    51991-795Rivastigmine TartrateRivastigmine Tartrate
    55111-354Rivastigmine TartrateRivastigmine Tartrate
    55111-355Rivastigmine TartrateRivastigmine Tartrate
    55111-353Rivastigmine TartrateRivastigmine Tartrate
    55111-352Rivastigmine TartrateRivastigmine Tartrate
    60429-394Rivastigmine TartrateRivastigmine Tartrate
    60429-393Rivastigmine TartrateRivastigmine Tartrate
    60505-3222Rivastigmine TartrateRivastigmine Tartrate
    60505-3221Rivastigmine TartrateRivastigmine Tartrate
    60429-396Rivastigmine TartrateRivastigmine Tartrate
    60429-395Rivastigmine TartrateRivastigmine Tartrate
    60505-3220Rivastigmine TartrateRivastigmine Tartrate
    60505-3223Rivastigmine TartrateRivastigmine Tartrate
    62756-145Rivastigmine TartrateRivastigmine Tartrate
    62756-148Rivastigmine TartrateRivastigmine Tartrate
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.